MedPath

Brain Imaging in the Idiopathic REM Sleep Behavior Disorder (ALICE)

Completed
Conditions
REM Sleep Behavior Disorder
Healthy
Interventions
Other: Clinical investigations
Registration Number
NCT03072940
Lead Sponsor
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
Brief Summary

Idiopathic rapid eye movement sleep behavior disorder (iRBD) is characterized by nocturnal violence, increased muscle tone during REM sleep and the lack of any other neurological disease. However, iRBD can precede parkinsonism and dementia by several years. The causes of the loss of muscle atonia during REM sleep in these patients are unclear. Using 3 T MRI and neuromelanin- sensitive sequences, the signal intensity was previously found to be reduce in the locus coeruleus/subcoeruleus area of patients with Parkinson's disease and RBD. Here, the investigators aimed at studying the integrity of the locus coeruleus/ subcoeruleus complex with neuromelanin-sensitive imaging in 21 patients with iRBD and compared the results with those from 21 age- and gender-matched healthy volunteers. All subjects will undergo a clinical examination, motor, cognitive, autonomous, psychological, olfactory and color vision tests, and rapid eye movement sleep characterization using video-polysomnography and 3 T magnetic resonance imaging.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • idiopathic RBD (criteria of the international classification of sleep disorders-3)

For healthy controls : no neurologic or psychiatric disorder

Exclusion Criteria
  • Contraindication to MRI
  • Do not speak French

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Healthy volunteersClinical investigations-
Patients with idiopathic RBDClinical investigations-
Primary Outcome Measures
NameTimeMethod
Signal in the subcoeruleus/coeruleus complex24h

Brain imaging signal in the subcoeruleus/coeruleus complex in 3T multimodal MRI, using neuromelanin-sensitive sequence

Secondary Outcome Measures
NameTimeMethod
Substantia nigra quantity24h

size of the substantia nigra

Quality of Sleep24h

Measures in videopolysomnography of efficiency of sleep

Cognition24h

Cognition status (MoCA test)

Olfactory function24h

Olfactory function (sniff test)

Color vision24h

Color vision function

Trial Locations

Locations (1)

Pitie Salpetriere hospital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath